drugset / Trial / NCT01012999

A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain

NCT01012999

Phase 1/2 Terminated 16 enrolled University of Utah
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the appropriate dose and effectiveness of intra-nasal administration of a potent narcotic, sufentanil, for the treatment of moderate to severe pain due to broken bone(s) in the arm or leg.

Timeline

Start
2009-11
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified 0.5 ug/kg Intranasal

Indications

No indication recorded.